-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
Lineage Cell Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and growth rate from Q2 2019 to Q2 2022.
- Lineage Cell Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending June 30, 2022 was $407K.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)